VKH
GSK icon

Virtu KCG Holdings’s GSK GSK Stock Holding History

Virtu KCG Holdings’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$919K Sell
17,054
-29,060
-63% -$1.55M 0.03% 631
2017
Q1 		$2.43M Buy
46,114
+11,651
+34% +$591K 0.07% 199
2016
Q4 		$1.66M Buy
34,463
+25,908
+303% +$1.28M 0.04% 408
2016
Q3 		$461K Sell
8,555
-24,389
-74% -$1.34M 0.01% 1463
2016
Q2 		$1.78M Buy
32,944
+21,180
+180% +$1.12M 0.04% 395
2016
Q1 		$596K Sell
11,764
-5,774
-33% -$288K 0.02% 1010
2015
Q4 		$885K Sell
17,538
-6,373
-27% -$325K 0.02% 972
2015
Q3 		$1.15M Sell
23,911
-12,271
-34% -$639K 0.02% 778
2015
Q2 		$1.88M Sell
36,182
-11,855
-25% -$667K 0.03% 469
2015
Q1 		$2.77M Sell
48,037
-281,340
-85% -$16.1M 0.06% 250
2014
Q4 		$17.6M Buy
329,377
+203,742
+162% +$11.4M 0.29% 29
2014
Q3 		$7.22M Buy
125,635
+95,250
+313% +$5.84M 0.14% 81
2014
Q2 		$2.03M Buy
30,385
+3,662
+14% +$248K 0.03% 535
2014
Q1 		$1.78M Buy
+26,723
New +$1.81M 0.02% 767
2013
Q4 		– Sell
-282,712
Closed -$18.3M – 3951
2013
Q3 		$17.7M Buy
+282,712
New +$18.2M 0.23% 52

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu KCG Holdings's GSK Position: Q2 2017 in Review

Virtu KCG Holdings reduced its GSK (GSK) stake by 63% in Q2 2017, selling an estimated $1.55M and leaving 17,054 shares worth $919K. The position accounts for 0.03% of the portfolio, ranked #631.

Virtu KCG Holdings first reported a position in GSK in Q3 2013 and has held it in 15 quarters since. The position peaked at $17.7M in Q3 2013. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

  • Virtu KCG Holdings held 17,054 shares of GSK worth $919K as of Q2 2017.
  • Virtu KCG Holdings sold 29,060 GSK shares in Q2 2017, an estimated $1.55M.
  • GSK made up 0.03% of Virtu KCG Holdings's portfolio in Q2 2017, its #631 holding.
  • Virtu KCG Holdings first reported a position in GSK in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's GSK position peaked at $17.7M in Q3 2013.
  • 779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.